نتایج جستجو برای: botox

تعداد نتایج: 636  

2013
Anja Bumb Burkhard Seifert Stephan Wetzel Reto Agosti

BACKGROUND To evaluate if white matter lesions (WML) on MRI can be a potential marker for onabotulinum toxin A (Botox®) treatment success in migraine, given the limited response rate and high costs per treatment. METHODS Retrospective data base and MRI analysis of 529 migraineurs who received Botox® between 2002 and 2009. Responders were defined as patients who underwent three or more treatme...

Journal: :The British journal of dermatology 2004
G M Kavanagh C Oh K Shams

We report two patients with severe palmar hyperhidrosis who responded to BOTOX delivered not by injection, the usual method of delivery, but by iontophoresis. The Botulinum molecule has been considered too large for delivery into the skin this way. However, other large peptides, both non-ionic and cationic, have been delivered successfully by this method, so we suspected that BOTOX could in fac...

Journal: :Journal of the American Academy of Dermatology 2010
Syrus Karsai Christian Raulin

To the Editor: The use of botulinum neurotoxin A is the most frequent intervention in aesthetic medicine. Sales of the two main preparations—Botox (Allergan Inc, Irvine, CA) and Dysport (Ipsen Ltd, Slough, Berkshire, UK)—amounted to USD $1 billion in 2007, and the trend is still growing. Even after 15 years of clinical use, the unit equivalence between these two main botulinum neurotoxin A prod...

2013
Hanan Mohamed El Kahky Heba Mahmoud Diab Dalia Gamal Aly Nehal Magdi Farag

Background. Two preparations of botulinum A toxin (BTX-A) are commercially available for the treatment of palmar hyperhidrosis (PPH): Botox (Allergan; 100 U/vial) and Dysport (Ipsen Limited; 500 U/vial), which are not bioequivalent. Results regarding an appropriate conversion factor between them are controversial. Objectives. This paper aims to compare the efficacy of Botox and Dysport in PPH u...

Journal: :Brazilian journal of otorhinolaryngology 2005
Dayse Manrique

AIM To demonstrate the effect of local application of Botox(R) in patients with amyotrophic lateral sclerosis (ALS), following our 2002 institutional protocol of sialorrhea treatment. STUDY DESIGN Clinical prospective. MATERIAL AND METHOD Five patients with ALS assisted at Clinic of Otolaryngology of AACD (Associação de Assistência à Criança Deficiente). They were all submitted to local app...

2013
P Kumar A Khattar R Goel A Kumar

Dear Editor, Smile is the most distinguished expression, and is the keystone of social interaction and communication. It is the universal welcoming greeting in all cultures and ethnicity. Just as a pleasant smile can act as a potential communication tool, an unpleasing smile can have the equally downbeat impact. Smile designing and functional restoration with dental implants, especially in part...

Journal: :Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2000
S F Ahsan R J Meleca J P Dworkin

OBJECTIVE This study was conducted to evaluate, subjectively and objectively, the diagnostic and therapeutic effects of botulinum toxin (Botox) in patients with dysphagia caused by cricopharyngeus (CP) muscle spasm and/or hypertonicity. METHODS A retrospective chart review was done of 5 patients with normally functioning larynges treated with CP Botox injection for dysphagia caused by perceiv...

Journal: :Frontiers of Oral and Maxillofacial Medicine 2021

Journal: :Aesthetic surgery journal 2004
Barry L Eppley

The author's study demonstrates that application of EMLA cream to treatment sites significantly reduces needle pain during Botox administration. Twenty patients receiving 200 Botox injections in the glabellar area experienced a 60% reduction in pain in EMLA-pretreated sites compared with that in matched control sites.

Journal: :Toxicon : official journal of the International Society on Toxinology 2011
Hongran F Stone Zhao Zhu Thai Q D Thach Curtis L Ruegg

RT002, an injectable form of botulinum neurotoxin type A (BoNTA), comprised of a purified 150 kDa neurotoxin formulated in a novel formulation, is designed to limit the extent of diffusion and permit safe administration of longer acting doses. The aim of this study was to evaluate the degree of diffusion of RT002 in comparison to another commercially available BoNTA product, Botox® Cosmetic (On...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید